The Week

Phillip Morris gained 4.67% this week to close at $191.06, while the S&P 500 fell 0.8%, leaving the stock about 5.47 percentage points ahead of the benchmark. The four-session week started soft and finished stronger: Tuesday opened near $181 and built higher, Wednesday chopped around the $185 level, Thursday broke toward $192 on heavier volume, and Friday touched an intraday high of $194.82 before settling back near $191. The upper wick on Friday’s bar suggests sellers emerged into strength.

Key Events

The main story this week was smoke-free products. On 8 September, the company attended the 2026 Barclays Global Consumer Conference and lifted its 2026 full-year reported diluted EPS outlook to $7.28 to $7.43, citing currency impact only. Management emphasised accelerating smoke-free growth in Japan and the U.S., with particular focus on IQOS and ZYN innovation, and tied the raised guidance to robust smoke-free momentum and expanded product offerings. Separately, HighTower Advisors disclosed a 9,240-share purchase on 7 September, a routine position change with limited informational value. The remaining headlines were market moves or sector chatter with no direct link to company fundamentals.

Analyst Ratings

Across 17 institutions covering the stock, 12 rate it buy or overweight (9 buy, 3 overweight), 4 rate it hold, and 1 has no opinion, with no underweight or sell ratings. The consensus rating is buy, and the consensus target price sits at $207.27, roughly 8.48% above Friday’s close of $191.06. Target prices range from $175 to $230, a spread of about $55 that points to disagreement on the higher end of the valuation range. Within the tobacco industry, the stock ranks No. 1 among 10 names by analyst rating.

The Week Ahead

On the macro side, the New York Fed manufacturing index lands on 15 September, followed on 16 September by retail sales, retail sales ex-autos, import prices and the NAHB housing market index. Retail sales are the one to watch: the previous print was negative and the consensus forecast points to a sharp rebound, making it a key test of U.S. consumer resilience. For Phillip Morris itself, the next major event is the fiscal Q3 2026 earnings release on 21 October, scheduled pre-market, with consensus estimates around $2.11 EPS and $11.2 billion in revenue.

In Short

The picture this week: the company used an industry conference to raise full-year guidance and highlight accelerating smoke-free growth, brokers maintain a buy consensus with a target above spot, and the stock beat the market by a wide margin. But Friday’s $194.82 high faded back to near $191, leaving an upper wick, and the latest session’s large-lot flow diverged from retail direction. At roughly 27x P/E and a 3.08% dividend yield, the stock sits between growth premium and defensive appeal. The next tests are whether retail sales data support risk appetite in consumer names, and whether the October earnings release confirms the smoke-free growth narrative.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.